Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status PED Q1 2026 Earnings Strong EPS Beat Highlights Operational Progress SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Terrestrial Energy IMSR Q1 2026 Earnings Narrowing Losses and a 14 Stock Surge Signal Investor Optimism Expion360 Q2 2025 Earnings EPS Beats Estimates by 307 Amid Cost Discipline TECX Q1 2026 Earnings WiderthanExpected Loss Amidst PreRevenue Stage SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback GPCR Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues RNGR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Firefly Neuroscience Inc AIFF Q3 1998 Earnings Steep Earnings Miss as PreRevenue Biotech Faces Cash Burn Headwinds YTRA Q1 2026 Earnings EPS Misses Estimates as Stock Rises 6 Ally Financial Q1 2026 Earnings EPS Surpasses Estimates by 165 Despite Small Stock Decline CSAI Q4 2025 Earnings EPS Loss Reported Amid Stock Decline